亚毫西弗低剂量胸部CT诊断COVID-19的准确性与可重复性
回顾性研究纳入2020年3月急诊192例疑似COVID-19患者,行低剂量胸部CT与RT-PCR对照。低剂量亚毫西弗胸部CT诊断COVID-19的敏感度86.7%、特异度93.6%、准确率90.2%,症状>48小时者敏感度95.6%、准确率94.4%;平均有效辐射剂量0.56 mSv,CT采集至报告中位时间25分钟。
要点
- 低剂量亚毫西弗胸部CT诊断COVID-19准确率高,症状>48小时者敏感度达95.6%。
- CT阳性时验后概率由43.2%升至91.1%,阴性时降至9.6%(症状>48小时者降至3.7%)。
- 平均有效辐射剂量0.56 mSv,CT采集至报告中位时间25分钟。
关键影像表现/征象
- CT图像分析包括COVID-19感染可能性及肺部受累半定量范围。
- 无COVID-19感染患者中,胸部CT提供替代诊断的患病率为17.6%。
诊断标准与关键数值
- 与RT-PCR对照,低剂量亚毫西弗胸部CT诊断COVID-19的敏感度86.7%、特异度93.6%、阳性预测值91.1%、阴性预测值90.3%、准确率90.2%。
- 症状>48小时患者中,敏感度95.6%、特异度93.2%、阳性预测值91.5%、阴性预测值96.5%、准确率94.4%。
- CT阳性患者验后概率由43.2%(验前概率)升至91.1%或91.4%;CT阴性患者验后概率降至9.6%(全部患者)或3.7%(症状>48小时者)。
临床应用与阅片要点
- 低剂量亚毫西弗胸部CT可用于急诊疑似COVID-19的快速评估,平均有效辐射剂量0.56 mSv±0.25(标准差)。
- CT采集至报告中位时间25分钟(四分位距13-49分钟),有助于急诊快速分诊。
- CT判读可重复性优秀(组内和组间ICC均≥0.95),Bland-Altman分析无显著偏倚。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To demonstrate the accuracy and reproducibility of low-dose submillisievert chest CT for the diagnosis of coronavirus disease 2019 (COVID-19) infection in patients in the emergency department.
MATERIALS AND METHODS: This was a Health Insurance Portability and Accountability Act-compliant, institutional review board-approved retrospective study. From March 14 to 24, 2020, 192 patients in the emergency department with symptoms suggestive of COVID-19 infection were studied by using low-dose chest CT and real-time reverse transcription polymerase chain reaction (RT-PCR). Image analysis included the likelihood of COVID-19 infection and the semiquantitative extent of lung involvement. CT images were analyzed by two radiologists blinded to the RT-PCR results. Reproducibility was assessed using the McNemar test and intraclass correlation coefficient. Time between CT acquisition and report was measured.
RESULTS: When compared with RT-PCR, low-dose submillisievert chest CT demonstrated excellent sensitivity, specificity, positive predictive value, negative predictive value, and accuracy for diagnosis of COVID-19 (86.7%, 93.6%, 91.1%, 90.3%, and 90.2%, respectively), in particular in patients with clinical symptoms for more than 48 hours (95.6%, 93.2%, 91.5%, 96.5%, and 94.4%, respectively). In patients with a positive CT result, the likelihood of disease increased from 43.2% (pretest probability) to 91.1% or 91.4% (posttest probability), while in patients with a negative CT result, the likelihood of disease decreased to 9.6% or 3.7% for all patients or those with clinical symptoms for >48 hours. The prevalence of alternative diagnoses based on chest CT in patients without COVID-19 infection was 17.6%. The mean effective radiation dose was 0.56 mSv ± 0.25 (standard deviation). Median time between CT acquisition and report was 25 minutes (interquartile range: 13-49 minutes). Intra- and interreader reproducibility of CT was excellent (all intraclass correlation coefficients ≥ 0.95) without significant bias in the Bland-Altman analysis.
CONCLUSION: Low-dose submillisievert chest CT allows for rapid, accurate, and reproducible assessment of COVID-19 infection in patients in the emergency department, in particular in patients with symptoms lasting longer than 48 hours. Chest CT has the additional advantage of offering alternative diagnoses in a significant subset of patients.© RSNA, 2020.
引用
- Dangis A, Gieraerts C, De Bruecker Y, et al. Accuracy and Reproducibility of Low-Dose Submillisievert Chest CT for the Diagnosis of COVID-19. Radiol Cardiothorac Imaging. 2020. PMID: 33778576. doi:10.1148/ryct.2020200196
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。